These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31206027)

  • 1. A boronic acid-rich dendrimer with robust and unprecedented efficiency for cytosolic protein delivery and CRISPR-Cas9 gene editing.
    Liu C; Wan T; Wang H; Zhang S; Ping Y; Cheng Y
    Sci Adv; 2019 Jun; 5(6):eaaw8922. PubMed ID: 31206027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology.
    Bai B; Myklebust JH; Wälchli S
    Methods Mol Biol; 2020; 2115():445-454. PubMed ID: 32006416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles.
    Liu J; Chang J; Jiang Y; Meng X; Sun T; Mao L; Xu Q; Wang M
    Adv Mater; 2019 Aug; 31(33):e1902575. PubMed ID: 31215123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNAzyme activated protein-scaffolded CRISPR-Cas9 nanoassembly for genome editing.
    Zhu X; Lv MM; Liu JW; Yu RQ; Jiang JH
    Chem Commun (Camb); 2019 Jun; 55(46):6511-6514. PubMed ID: 31099367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
    Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
    Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements.
    Lattanzi A; Meneghini V; Pavani G; Amor F; Ramadier S; Felix T; Antoniani C; Masson C; Alibeu O; Lee C; Porteus MH; Bao G; Amendola M; Mavilio F; Miccio A
    Mol Ther; 2019 Jan; 27(1):137-150. PubMed ID: 30424953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.
    Zhang S; Shen J; Li D; Cheng Y
    Theranostics; 2021; 11(2):614-648. PubMed ID: 33391496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly efficient genome editing by homology-directed repair using Cas9 protein in Ceratitis capitata.
    Aumann RA; Schetelig MF; Häcker I
    Insect Biochem Mol Biol; 2018 Oct; 101():85-93. PubMed ID: 30157456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome Editing in a Wide Area of the Brain Using Dendrimer-Based Ternary Polyplexes of Cas9 Ribonucleoprotein.
    Taharabaru T; Yokoyama R; Higashi T; Mohammed AFA; Inoue M; Maeda Y; Niidome T; Onodera R; Motoyama K
    ACS Appl Mater Interfaces; 2020 May; 12(19):21386-21397. PubMed ID: 32315156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscale metal-organic frameworks for the intracellular delivery of CRISPR/Cas9 genome editing machinery.
    Zheng Q; Li W; Mao L; Wang M
    Biomater Sci; 2021 Oct; 9(21):7024-7033. PubMed ID: 34378567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient Genome Editing Achieved via Plug-and-Play Adenovirus Piggyback Transport of Cas9/gRNA Complex on Viral Capsid Surface.
    Lu ZH; Li J; Dmitriev IP; Kashentseva EA; Curiel DT
    ACS Nano; 2022 Jul; 16(7):10443-10455. PubMed ID: 35749339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing.
    Chang J; Chen X; Glass Z; Gao F; Mao L; Wang M; Xu Q
    Acc Chem Res; 2019 Mar; 52(3):665-675. PubMed ID: 30586281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-type-specific genome editing with a microRNA-responsive CRISPR-Cas9 switch.
    Hirosawa M; Fujita Y; Parr CJC; Hayashi K; Kashida S; Hotta A; Woltjen K; Saito H
    Nucleic Acids Res; 2017 Jul; 45(13):e118. PubMed ID: 28525578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9 in genome editing: Its function and medical applications.
    Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
    J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas systems: ushering in the new genome editing era.
    Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
    Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivering SaCas9 mRNA by lentivirus-like bionanoparticles for transient expression and efficient genome editing.
    Lu B; Javidi-Parsijani P; Makani V; Mehraein-Ghomi F; Sarhan WM; Sun D; Yoo KW; Atala ZP; Lyu P; Atala A
    Nucleic Acids Res; 2019 May; 47(8):e44. PubMed ID: 30759231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-C: circularization of genes and chromosome by CRISPR in human cells.
    Møller HD; Lin L; Xiang X; Petersen TS; Huang J; Yang L; Kjeldsen E; Jensen UB; Zhang X; Liu X; Xu X; Wang J; Yang H; Church GM; Bolund L; Regenberg B; Luo Y
    Nucleic Acids Res; 2018 Dec; 46(22):e131. PubMed ID: 30551175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
    Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
    Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
    Vermersch E; Jouve C; Hulot JS
    Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.